Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-03 PAKOLA STEVE Chief Medical Officer Grant or award · Stock Options (Right to buy) +44,155 44,155
2023-01-03 Mills Kenneth T. President and CEO Shares withheld for taxes −9,308 $22.68 $211K 300,536
2023-01-03 Mills Kenneth T. President and CEO Grant or award +54,753 355,289
2023-01-03 Mills Kenneth T. President and CEO Grant or award · Stock Options (Right to buy) +264,932 264,932
2023-01-03 Danos Olivier Chief Scientific Officer Shares withheld for taxes −2,058 $22.68 $47K 27,020
2023-01-03 Danos Olivier Chief Scientific Officer Grant or award +65,930 92,950
2023-01-03 Danos Olivier Chief Scientific Officer Grant or award · Stock Options (Right to buy) +52,986 52,986
2023-01-03 Christmas Patrick J. Chief Legal Officer Shares withheld for taxes −1,843 $22.68 $42K 21,097
2023-01-03 Christmas Patrick J. Chief Legal Officer Grant or award +67,940 89,037
2023-01-03 Christmas Patrick J. Chief Legal Officer Grant or award · Stock Options (Right to buy) +56,519 56,519
2022-08-30 Vasista Vittal Chief Financial Officer Sale −2,400 $30.24 $73K 135,160
2022-08-05 Vasista Vittal Chief Financial Officer Sale −17,280 $35.19 $608K 137,560
2022-08-04 Vasista Vittal Chief Financial Officer Sale −400 $35.00 $14K 154,840
2022-08-01 Vasista Vittal Chief Financial Officer Sale −2,400 $31.26 $75K 155,240
2022-07-14 Vasista Vittal Chief Financial Officer Sale −468 $30.00 $14K 157,640
2022-07-13 Vasista Vittal Chief Financial Officer Sale −4,332 $30.01 $130K 158,108
2022-06-30 Danos Olivier Chief Scientific Officer Grant or award +728 $21.00 $15K 93,678
2022-06-03 Zachary Jennifer Director Grant or award +6,020 6,020
2022-06-03 Zachary Jennifer Director Grant or award · Stock Option (Right to Buy) +29,739 29,739
2022-06-03 Tasse Daniel Director Grant or award +3,010 3,010

Page 13 of 25 · 494 trades